Form 8-K BIOGEN INC. For: Jul 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Crude Inventory Rose 2 Million Barrels Last Week - EIA
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
Biogen expects $164M R&D charge to hit Q2 2026 earnings
July 1, 2026 4:09 PM EDTBiogen Inc. (NASDAQ: BIIB) has disclosed that its second-quarter 2026 results will include an acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis, according to a company statement.
The charge is expected to reduce both GAAP and... More
